other material
confidence high
sentiment neutral
materiality 0.60
Aspire Biopharma clarifies warrant terms after two reverse splits; exercise price now $13,800
Aspire Biopharma Holdings, Inc.
- Original exercise price of $11.50 per share adjusted to $13,800 after 1-for-30 and 40-1 reverse splits.
- Warrant ratio changed to 1,200 warrants to purchase one share of common stock.
- Reverse splits effective January 16, 2026 and May 11, 2026.
- Clarification provided in response to requests from public warrant holders.
- Warrants trade under symbol ASBPW on Nasdaq.